ARTELO BIOSCIENCES, INC.
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
ARTL | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 505 LOMAS SANTA FE, SUITE 160, 92075 SOLANA BEACH
- Website:
- https://artelobio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics. The company's scientific platform focuses on modifying lipid-signaling pathways, including the endocannabinoid system, to develop treatments for a range of conditions. Its primary focus is on improving therapies for patients with cancer, with additional programs targeting acute and chronic conditions such as pain, anxiety, and depression.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ARTELO BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARTELO BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARTELO BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
